Literature DB >> 192417

Ontogeny of beta-adrenergic receptors in rat cerebral cortex.

T K Harden, B B Wolfe, J R Sporn, J P Perkins, P B Molinoff.   

Abstract

The ontogeny of beta-adrenergic receptors in rat cerebral cortex has been studied using [125I]iodohydroxybenzylpindolol as a ligand in an in vitro binding assay. The concentration of beta-adrenergic receptors was very low during the first week after birth. Between days 7 and 14 there was a rapid increase in the density of receptors. Adult levels were reached by the end of the second week. The affinities of 1-isoproterenol and iodohydroxybenzylpindolol for beta-adrenergic receptors did not vary with the age of the animal. Fluoride stimulated adenylate cyclase activity in the cerebral cortex was 40% of the adult level at birth and gradually increased to maximal levels over the next two weeks. On the other hand, catecholamine stimulated cyclic-3',5'-adenosine monophosphate accumulation was barely detectable during the first week after birth, but it increased rapidly to adult levels between days 7 and 14. The results suggest that it is the development of beta-adrenergic receptors that permits the expression of catecholamine sensitive adenylate cyclase activity. Norepinephrine stores in the cerebral cortex developed slowly reaching adult levels approximately two months after birth. There is therefore little correlation between the ontogeny of presynaptic adrenergic nerve terminals and the postsynaptic development of beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192417     DOI: 10.1016/0006-8993(77)90362-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults.

Authors:  L Charles Murrin; Jeff D Sanders; David B Bylund
Journal:  Biochem Pharmacol       Date:  2007-01-25       Impact factor: 5.858

Review 2.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

3.  Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neocortical explants is seen only with the beta-1, not with the beta-2 subtype.

Authors:  G J Boer; A A Kellerman; R E Baker; P te Riele; M G Feenstra; M Botterblom; B H Erdtsieck-Ernste
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

4.  Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2018-03-07       Impact factor: 4.221

5.  Atomoxetine facilitates attentional set shifting in adolescent rats.

Authors:  Rachel E Cain; Michelle C Wasserman; Barry D Waterhouse; Jill A McGaughy
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

6.  Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs.

Authors:  S G Rockson; C J Homcy; P Quinn; W T Manders; E Haber; S F Vatner
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

7.  Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the pre-weanling rat.

Authors:  F J Seidler; T A Slotkin
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

8.  Effects of maturation and aging on behavioral responses to haloperidol in the rat.

Authors:  A Campbell; R J Baldessarini
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Maturation of monoamine neurotransmitters and receptors in cat occipital cortex during postnatal critical period.

Authors:  G Jonsson; T Kasamatsu
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

10.  Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.

Authors:  P Guicheney; P Meyer
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.